Solange Peters
Fortuna: 186 061 $ al 31/08/2026
Fortuna: 186 061 $ al 31/08/2026
Solange Peters is currently Director at Swiss Cancer League since 2017, Independent Director at Galenica AG since 2023, Independent Director at Transgene SA, President of the International Cancer Foundation since 2021, Member of the European Society for Medical Oncology, and Head of the Department of Medical Oncology at Centre Hospitalier Universitaire Vaudois since 2002.
Formerly, Dr. Peters was Professor at the University of Lausanne from 2002 to 2006.
Education includes a doctorate from the University of Lausanne.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GALENICA AG 0 % | 31/12/2025 | 1.809 ( 0 % ) | 186 061 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GALENICA AG | Director/Miembro de la Junta | 11/05/2023 |
| TRANSGENE | Director/Miembro de la Junta | - |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
Swiss Cancer League | Director/Miembro de la Junta | 01/01/2017 |
International Cancer Foundation
International Cancer Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Presidente | 01/01/2021 |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Operates university hospitals | Corporate Officer/Principal | 01/01/2002 |
| Empresas | Cargo | Fin |
|---|---|---|
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2006 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
Swiss Cancer League | |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Operates university hospitals | Health Services |
Galenica AG
Galenica AG Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals and healthcare products | Distribution Services |
International Cancer Foundation
International Cancer Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.